Can you help with regulatory documentation?
Yes, we assist with study design, data reporting, and regulatory readiness for submissions.
What kind of inhalation devices do you work with?
We support dry powder inhalers (DPI), metered dose inhalers (MDI), nebulisers, and customised delivery platforms.
Do you provide both in vitro and in vivo services?
Yes, through our consortium we support a full range of inhalation-specific pre-clinical studies.
What is pre-clinical inhalation development?
It includes early-stage studies to assess safety, efficacy, and pharmacokinetics of inhaled drugs before entering clinical trials.
Can you help optimise an existing dry powder inhaler formulation?
Yes, we offer reformulation and troubleshooting support to improve performance or meet updated regulatory requirements.
How do you approach dry formulation development?
We evaluate powder properties, device compatibility, and stability to ensure consistent dosing and optimal lung deposition.
What is powder inhalation?
Powder inhalation involves delivering drugs in dry powder form directly to the lungs using DPI devices. It offers convenience and effective local or systemic delivery.
What is dry powder formulation development?
It refers to the development of inhaled drug formulations designed for delivery to the lungs, with a focus on performance, stability, and compatibility with devices.
Can characterisation be tailored to specific regulatory requirements?
Yes, we adapt all testing protocols to meet the specific needs of each project and the relevant regulatory guidelines.
What types of devices do you test?
We test a wide range of inhaler types including MDIs, DPIs and nebulisers. Our dry powder inhaler testing services are designed to support both early and late-phase development.